Matches in SemOpenAlex for { <https://semopenalex.org/work/W3100905500> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W3100905500 endingPage "665" @default.
- W3100905500 startingPage "660" @default.
- W3100905500 abstract "BACKGROUND Some surgeons advocate the usage of tranexamic acid (TXA) in traumatic brain injury (TBI). The aim of this study is to determine the effectiveness and safety of TXA in improving the outcome of TBI patients and in reducing the rate of clot expansion and mortality in TBI as compared to those without TXA. METHODS This is a prospective observational cohort study conducted in Sarawak General Hospital, Malaysia. Patients 12 years of age and older with mild to severe TBI who had a brain computed tomography (CT) done within eight hours of injury were enrolled in the study. A total of 334 patients were recruited from the 5th of August 2016 until the 8th of March 2018 in Sarawak General Hospital. In all 167 of them were administered with TXA and another 167 of the patients were not. The primary outcome expected is the number of good outcomes in isolated TBI patients given TXA. Good outcome is defined by Glasgow Outcome Score-Extended (GOSE) of five and above. Secondary outcome was clot expansion of an intracranial bleed seen on the first scan that had expanded by 25% or more on any dimension on the second scan. RESULTS The TXA did not show significant trend of good outcome in terms of GOSE (p=0.763). However, for moderate and severe acute subdural haemorrhage (SDH) subgroups, there was a significant difference (p=0.042). Clot expansion was present in 14 patients (12.7%) with TXA given and in 54 patients (38.8%) without TXA. The difference was statistically significant (p<0.001). Of the patients who received TXA, there was one case (0.6%) of deep vein thrombosis. Apart from that, TXA showed non-significant trend in reducing mortality (p=0.474). CONCLUSIONS Tranexamic acid reduces the rate of clot expansion in TBI by 26.1% (38.8-12.7%) without significantly increasing the risk of a thrombotic event. It can also improve the outcome of moderate and severe TBI patients with acute SDH." @default.
- W3100905500 created "2020-11-23" @default.
- W3100905500 creator A5005658769 @default.
- W3100905500 creator A5009079415 @default.
- W3100905500 creator A5069557885 @default.
- W3100905500 date "2020-11-01" @default.
- W3100905500 modified "2023-09-23" @default.
- W3100905500 title "Tranexamic acid in traumatic brain injury." @default.
- W3100905500 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33219174" @default.
- W3100905500 hasPublicationYear "2020" @default.
- W3100905500 type Work @default.
- W3100905500 sameAs 3100905500 @default.
- W3100905500 citedByCount "1" @default.
- W3100905500 crossrefType "journal-article" @default.
- W3100905500 hasAuthorship W3100905500A5005658769 @default.
- W3100905500 hasAuthorship W3100905500A5009079415 @default.
- W3100905500 hasAuthorship W3100905500A5069557885 @default.
- W3100905500 hasConcept C118552586 @default.
- W3100905500 hasConcept C126322002 @default.
- W3100905500 hasConcept C141071460 @default.
- W3100905500 hasConcept C188816634 @default.
- W3100905500 hasConcept C2776259030 @default.
- W3100905500 hasConcept C2777796830 @default.
- W3100905500 hasConcept C2779637338 @default.
- W3100905500 hasConcept C2781017439 @default.
- W3100905500 hasConcept C2991743468 @default.
- W3100905500 hasConcept C42219234 @default.
- W3100905500 hasConcept C71924100 @default.
- W3100905500 hasConceptScore W3100905500C118552586 @default.
- W3100905500 hasConceptScore W3100905500C126322002 @default.
- W3100905500 hasConceptScore W3100905500C141071460 @default.
- W3100905500 hasConceptScore W3100905500C188816634 @default.
- W3100905500 hasConceptScore W3100905500C2776259030 @default.
- W3100905500 hasConceptScore W3100905500C2777796830 @default.
- W3100905500 hasConceptScore W3100905500C2779637338 @default.
- W3100905500 hasConceptScore W3100905500C2781017439 @default.
- W3100905500 hasConceptScore W3100905500C2991743468 @default.
- W3100905500 hasConceptScore W3100905500C42219234 @default.
- W3100905500 hasConceptScore W3100905500C71924100 @default.
- W3100905500 hasIssue "6" @default.
- W3100905500 hasLocation W31009055001 @default.
- W3100905500 hasOpenAccess W3100905500 @default.
- W3100905500 hasPrimaryLocation W31009055001 @default.
- W3100905500 hasRelatedWork W2027592211 @default.
- W3100905500 hasRelatedWork W2086088193 @default.
- W3100905500 hasRelatedWork W2462101562 @default.
- W3100905500 hasRelatedWork W2642806922 @default.
- W3100905500 hasRelatedWork W2752930776 @default.
- W3100905500 hasRelatedWork W2753094917 @default.
- W3100905500 hasRelatedWork W2883332335 @default.
- W3100905500 hasRelatedWork W2904294604 @default.
- W3100905500 hasRelatedWork W2975909478 @default.
- W3100905500 hasRelatedWork W3015259488 @default.
- W3100905500 hasRelatedWork W3027897538 @default.
- W3100905500 hasRelatedWork W3088821457 @default.
- W3100905500 hasRelatedWork W3093077718 @default.
- W3100905500 hasRelatedWork W3108314933 @default.
- W3100905500 hasRelatedWork W3133887532 @default.
- W3100905500 hasRelatedWork W3153336489 @default.
- W3100905500 hasRelatedWork W3157684762 @default.
- W3100905500 hasRelatedWork W3159286051 @default.
- W3100905500 hasRelatedWork W3174158234 @default.
- W3100905500 hasRelatedWork W3200964605 @default.
- W3100905500 hasVolume "75" @default.
- W3100905500 isParatext "false" @default.
- W3100905500 isRetracted "false" @default.
- W3100905500 magId "3100905500" @default.
- W3100905500 workType "article" @default.